Skip to content
Head to head

10x Genomics vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: TXG · ABT

Updated moments ago

1-year performance, rebased to 100

TXG +229.9%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
TXGABT
Snapshot
Sector--Medical Devices
Last price51.80103.00
Change today-9.72%-0.84%
1-year return+214.7%-15.4%
Market cap$6.81B$178.39B
52-week range15.18 – 102.8180.89 – 126.70
Valuation
P/E (TTM)-99.6238.29
P/E percentile, own 5-yr range12th99th
P/B8.133.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-0.353.72
Net profit (TTM)$-46.04M$6.44B
Revenue (TTM)$618.58M$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+1.1%+14.5%
Gross margin71.9%56.9%
Operating margin-12.2%13.8%
Net margin-10.8%9.7%
Free cash flow (TTM)$93.77M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership101.5%81.2%
Insider activity (12mo)11 buy / 38 sell36 buy / 12 sell
Short interest (% of float)9.6%1.1%
Analyst consensus38% buy / 62% hold (13)93% buy / 7% hold (15)
Analyst price target$76 (+47%)$122 (+18%)
StockVane view
StockVane Quant RatingC (100)D (22)
Company
Employees1,178115,000
Founded20121900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.